Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Rebecca Deya, MSN, RN
Research Manager
Baptist MD Anderson Clinical Trials
904.202.7468
rebecca.deya@bmcjax.com
Clinical Trial ID: NCT04729959
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
Status
Open
Conditions
Other
Phases
II
Age Group
Adult
Main Investiagtor
Cavaliere, Robert
Practice
CNS
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT04729959
Secondary Trial ID Number
BN010
Keywords
Treatment